NMT Medical announces preliminary unaudited figures for fiscal 2009

NewsGuard 100/100 Score

NMT Medical, Inc. (NASDAQ: NMTI) today announced that it expects to report full year 2009 revenues of approximately $13.2 million – within the Company’s previously-announced guidance range of $13 million to $14 million. For the fourth quarter of 2009, NMT expects to report revenues of approximately $3.6 million compared with $3.0 million in the third quarter of 2009 and $4.4 million in the year-ago quarter.

“Our pivotal patent foramen ovale (PFO)/stroke and transient ischemic attack (TIA) trial in the United States, CLOSURE I, remains our top priority”

NMT also expects to report a year-end balance of cash and cash equivalents of approximately $8.9 million. As previously reported, NMT reached a settlement during the fourth quarter in its patent infringement lawsuit with W.L. Gore & Associates, resulting in a $2.75 million cash payment to NMT.

“Our pivotal patent foramen ovale (PFO)/stroke and transient ischemic attack (TIA) trial in the United States, CLOSURE I, remains our top priority,” said President and Chief Executive Officer Frank Martin. “As previously announced, data analysis for the trial is expected to be initiated in April 2010. We believe that commencing the data review at that time will allow us to submit a Pre-Market Approval (PMA) application during the third quarter of 2010, assuming a positive outcome.”

Source:

NMT Medical, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Income and education linked to lower post-stroke mortality